Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldWebinar

Webinar On ADHD: Diagnosis and Subtyping


Add this event to your calendar: iCal   Google Calendar

Who should attend?

Psychologists Psychiatrists Counselors Clinical Social Workers Psychiatric Nurses

Details

Training Options  Duration: 60 Minutes  
Thursday, May 24, 2018   |   10:00 AM PDT | 01:00 PM EDT

Overview:    In this program Dr. Barkley provides detailed information on the specific nature of ADHD symptoms as revealed by clinical research so as to better inform the current diagnostic criteria for ADHD. He then reviews the various modifications necessary for updating the DSM criteria and making them more useful with special populations (girls, adults, etc.).

He also addresses the changes that are still needed to improve these diagnostic criteria based on findings in the research literature. Dr. Barkley then addresses the issue of subtyping of ADHD along with the emerging conclusion that one form of the inattentive type may constitute a new disorder known in research as sluggish cognitive tempo or sometimes called ADD by clinicians. 

Why should you Attend: Attendance will familiarize you with the latest criteria for diagnosing ADHD in children and adults including not just the DSM-5 criteria, but also the modifications that are essential for applying those diagnostic criteria to special populations (girls, adults, etc.). These modifications were well documented in research over the past decade yet went ignored in the final version of DSM-5. You will find that clinicians can not afford to ignore such evidenced-based adjustments that permit a more rigorous approach to the diagnosis of ADHD than that permitted in the DSM-5 criteria. 

These criteria will also be further informed by the latest clinical research perspective on the nature of ADHD as a disorder of executive functioning and self-regulation. The clinical implications of this perspective are far more useful for understanding the management of ADHD than is the attention deficit perspective. 

Furthermore, those attending will learn about the new disorder of attention known as sluggish cognitive tempo that has come to replace the earlier Inattentive Type of ADHD, a subtype no longer recognized in DSM-5 as it has been demoted to a presentation. You won’t want to miss out on these cutting edge discoveries and their clinical implications as presented by an international authority on ADHD who tracks the published research findings weekly and brings those findings into his presentations. 

Areas Covered in the Session:

The current research clinical view of ADHD
The nature of the attention and inhibition problems evident in ADHD
Understanding ADHD as a disorder of executive functioning
The DSM-5 criteria
The problems with DSM-5 criteria and how to fix them
The problems with earlier DSM subtyping of ADHD and a more recent alternative approach
The nature of sluggish cognitive tempo – a distinct disorder of attention from ADHD that can be comorbid with it

Who Will Benefit:
Psychologists
Psychiatrists
Counselors
Clinical Social Workers
Psychiatric Nurses

Speaker Profile 
Russell A. Barkley Russell A. Barkley, Ph.D., is a Clinical Professor of Psychiatry at the Virginia Treatment Center for Children and Virginia Commonwealth University Medical Center, Richmond, VA. He is a Diplomate (board certified) in three specialties, Clinical Psychology (ABPP), Clinical Child and Adolescent Psychology, and Clinical Neuropsychology (ABCN, ABPP). 

Dr. Barkley is a clinical scientist, educator, and practitioner who has published 23 books, rating scales, and clinical manuals numbering 41 editions. He has also published more than 270 scientific articles and book chapters related to the nature, assessment, and treatment of ADHD and related disorders. He is the founder and Editor of the bimonthly clinical newsletter, The ADHD Report, now in its 25th year of publication. Dr. Barkley has presented more than 800 invited addresses internationally and appeared on nationally televised programs such as 60 Minutes, the Today Show, Good Morning America, CBS Sunday Morning, CNN, and many other programs on behalf of those with ADHD. 

Price - $139

Contact Info:
Netzealous - MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884 
Email: support@mentorhealth.com
Website: http://www.mentorhealth.com/
Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/
 

Prices

Price: $139.00

Contact

Roger Steven
support@mentorhealth.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.